Skip to main content

When Olympic cycling legend, Sir Chris Hoy announced that he was diagnosed with cancer it came as a shock to many.  Later, he confirmed that he had been diagnosed with prostate cancer that had advanced to stage 4, which is the most advanced stage of cancer.    

Sir Chris has launched “Tour de 4” which aims to shine a spotlight on what a stage 4 cancer diagnosis can look like and demonstrate that it is possible to live well and lead a happy life alongside this devastating diagnosis.

Zwift, has joined as a as a founding partner with rides to be held on the platform until August 2025 and will also match all charitable donations made by the community up to £50,000.

About Tour de 4

The Tour de 4 is an initiative launched by Sir Chris Hoy to change the perception of people living with stage 4 cancer, and to raise vital funds for cancer charities across the UK. Tour de 4 also aims to be a means for those affected by cancer to connect with others. 

Tour de 4 on Zwift

The Tour de 4 will be held on Zwift from February 8th through to August. Zwift is encouraging as many people as possible to join the rides and to donate to the cancer charities that mean the most to them, with Zwift matching all donations made by the community up to £50,000. 

“A huge thank you to the team at Zwift for their investment and support. Tour de 4 is all about bringing people together and Zwift is the perfect platform to do this; I get so much out of my Zwift rides, meeting and engaging with a brilliant community. I’m particularly excited to have a few special guests confirmed for the 8th so come and join us if you can – you never know who you might end up riding alongside!”

About the event

Sir Chris Hoy will be joined on February 8th by special guests including Philip Hindes, Duncan Scott, Lucy Charles-Barclay, Sam Laidlow, and Freddy Ovett.

The event is designed as a Saturday social ride, and will start at 10am GMT for a 45-minute spin around the Tempus Fugit course on Watopia.

About prostate cancer

For more information about the cancer, visit Prostate Cancer UK or click here.